Analysis of pathogenesis and control of arthritis in rheumatoid arthritis by calpain-calpastatin system
Analysis of pathogenesis and control of arthritis in rheumatoid arthritis by calpain-calpastatin system
批准号:
16390287
负责人:
MIMORI Tsuneyo
金额:
$9.22万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
我们之前报道过,类风湿性关节炎(RA)患者自身抗体识别的靶自身抗原之一是钙依赖性半胱氨酸蛋白酶(calpain)的内源性抑制剂calpastatin, RA患者血清中的IgG部分抑制calpastatin的功能并增加calpain的蛋白水解活性。钙蛋白酶被认为是一种中性蛋白酶,调节各种炎症因子的激活,并可能参与软骨降解。本研究旨在通过calpain-calpastatin系统探讨RA的发病机制及新的治疗策略。calpain抑制剂E-64-d对小鼠关节炎模型的改善作用腹腔注射calpain抑制剂E-64-d能明显抑制Balb/c小鼠单克隆抗II型胶原抗体诱导的关节炎。定量RT-PCR结果显示,e -64-d处理小鼠关节组织中IL-1和IL-6 mRNA水平明显受到抑制。当添加E-64-d时,RA患者培养的滑膜细胞中IL-6和IL-1的产生也呈剂量依赖性地受到抑制。calpastatin过表达对成纤维细胞和T细胞活化的影响Th1细胞中calpastatin的自然表达明显低于Th2细胞,尤其是活化的Th1细胞。用人钙pastatin cdna -重组逆转录病毒载体转染Balb/c小鼠脾CD4+T细胞和3T3成纤维细胞后,IL-6和干扰素-γ的产生明显受到抑制。因此,在RA患者中,钙蛋白酶活性的增加可能通过CD4+T细胞从Th2分化到Th1,以及滑膜细胞中IL-6的过度产生参与关节炎的恶化。
英文摘要
We have previously reported that one of target autoantigens recognized by autoantibodies in rheumatoid arthritis (RA) patients is calpastatin, an endogenous inhibitor of calcium-dependent cysteine proteinase (calpain), and that IgG fraction of RA patient sera inhibits the function of calpastatin and increases the proteolytic activity of calpain. Calpain is thought to be a neutral proteinase that regulates activation of various inflammation factors and may be involved in cartilage degradation. Our study aims to investigate the pathogenesis and new therapeutic strategy of RA by calpain-calpastatin system.1.Amelioration of mouse model arthritis by calpain inhibitorMonoclonal anti-type II collagen antibodies-induced arthritis in Balb/c mice was significantly inhibited by intraperitoneal injection of calpain inhibitor E-64-d. Quantitative RT-PCR demonstrated that mRNA levels of IL-1 and IL-6 were significantly suppressed in the joint tissues of E-64-d-treated mice. Production of IL-6 and IL-1 was also suppressed in dose-dependent manner in cultured synoviocytes from RA patients when E-64-d was added.2.Effect of over expression of calpastatin in activation of fibroblasts and T cellsNatural expression of calpastatin was significantly decreased in Th1 cells, especially in activated Th1 cells, than in Th2 cells. When splenic CD4+T cells from Balb/c mice and 3T3 fibroblasts were transfected by human calpastatin cDNA-recombinant retrovirus vector, production of IL-6 and interferon-γ was significantly suppressed.Thus, in RA patients, increased calpain activity may be involved in exacerbation of arthritis by differentiating CD4+T cells from Th2 to Th1, as well as over production of IL-6 in synovial cells.
期刊论文(7)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2169/internalmedicine.44.1122
发表时间:
2005-11
期刊:
Internal medicine
影响因子:
1.2
作者:
[T. Mimori]
通讯作者:
T. Mimori
DOI:
10.1002/art.20023
发表时间:
2004-02-01
期刊:
ARTHRITIS AND RHEUMATISM
影响因子:
--
作者:
[Kawabata, D, Tanaka, M, Ozaki, S]
通讯作者:
Ozaki, S
関節リウマチ早期診断と抗CCP抗体
类风湿性关节炎的早期诊断和抗CCP抗体
DOI:
--
发表时间:
2005
期刊:
リウマチ科 34(3)
影响因子:
--
作者:
[Ichikawa Y, Mimori T, et al., 三森経世]
通讯作者:
三森経世
DOI:
10.1084/jem.20041685
发表时间:
2005-07-18
期刊:
The Journal of experimental medicine
影响因子:
--
作者:
[Miyaji M, Jin ZX, Yamaoka S, Amakawa R, Fukuhara S, Sato SB, Kobayashi T, Domae N, Mimori T, Bloom ET, Okazaki T, Umehara H]
通讯作者:
Umehara H
DOI:
10.1002/art.21023
发表时间:
2005-05-01
期刊:
ARTHRITIS AND RHEUMATISM
影响因子:
--
作者:
[Sato, S, Hirakata, M, Ikeda, Y]
通讯作者:
Ikeda, Y
Study for pathological significance of autoantibodies and establishment of therapy in myositis-associated intractable acute interstitial pneumonia
-
批准号:25293222
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2013
-
负责人:MIMORI Tsuneyo
-
依托单位:
Analysis of pathogenicity and development of novel therapy byinflammation-regulating proteins in systemic autoimmune diseases
-
批准号:22390201
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.98万
-
财政年份:2010
-
负责人:MIMORI Tsuneyo
-
依托单位:
Clinical and pathophysiological significance of novel identified anti-IFIH1/MDA5 autoantibody in amyopathic dermatomyositis
-
批准号:22659185
-
项目类别:Grant-in-Aid for Challenging Exploratory Research
-
资助金额:$2.07万
-
财政年份:2010
-
负责人:MIMORI Tsuneyo
-
依托单位:
Analysis of pathophysiology and novel therapeutic approach for rheumatic diseases by arthritis-regulated proteins
-
批准号:18390290
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.58万
-
财政年份:2006
-
负责人:MIMORI Tsuneyo
-
依托单位:
Significance of anti-calpastatin antibodies in rheumatic diseases and their effect on osteoclast
-
批准号:12670437
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.05万
-
财政年份:2000
-
负责人:MIMORI Tsuneyo
-
依托单位:
Clinical and pathogenic significance and its therapeutic application of anti-calpastatin antibodies in rheumatoid arthritis
-
批准号:09670492
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.98万
-
财政年份:1997
-
负责人:MIMORI Tsuneyo
-
依托单位:
Clinical and pathological significance of autoantibodies to calpastatin in rheumatoid arthritis
-
批准号:07670540
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$1.54万
-
财政年份:1995
-
负责人:MIMORI Tsuneyo
-
依托单位:
Function of the DNA-terminal binding protein regognized by anti-Ku antibodies and its etiologic significance in collagen disease
-
批准号:04670395
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1992
-
负责人:MIMORI Tsuneyo
-
依托单位:
Cloning of cDNA encoding the DNA-terminal binding protein (Ku)
-
批准号:01570369
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.41万
-
财政年份:1989
-
负责人:MIMORI Tsuneyo
-
依托单位:
Molecular cloning of a DNA-end-binding protein (Ku antigen) recognized by autoantibodies and its application.
-
批准号:62570296
-
项目类别:Grant-in-Aid for General Scientific Research (C)
-
资助金额:$1.34万
-
财政年份:1987
-
负责人:MIMORI Tsuneyo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Wnt5a/Calpain6/Rac1通路激活毛囊黑素干细胞逆转毛发白化的机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:星懿展
-
依托单位:
矢车菊素-3-O-葡萄糖苷通过miR-137-3p抑制Calpain-2/β-catenin通路降低胶质瘤细胞干性的信号机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:
-
依托单位:
Calpain活化在线粒体稳态失衡引起噪声性耳蜗损伤中的作用机制
-
批准号:82330034
-
项目类别:重点项目
-
资助金额:220万元
-
批准年份:2023
-
负责人:殷善开
-
依托单位:
Calpain通过MYC-DHODH促进铁死亡介导早期心肌损伤在病毒性心肌炎中的作用及机制研究
-
批准号:82370361
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:陈瑞珍
-
依托单位:
Calpain/P-eIF2α动态平衡在黄芪甲苷IV治疗顺铂肾损伤中的机制研究
-
批准号:82360738
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:寇温
-
依托单位:
热休克蛋白90对calpain-1的变构调节机制及其对鸡肉嫩度的影响
-
批准号:32372406
-
项目类别:面上项目
-
资助金额:50.00万元
-
批准年份:2023
-
负责人:张牧焓
-
依托单位:
靶向抑制线粒体calpain截切ATP5A1蛋白在防治心力衰竭中的关键作用和机制研究
-
批准号:82370388
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:曹婷
-
依托单位:
Calpain调节Kupffer细胞内质网应激介导NLRP3活化促进肝纤维化的机制研究
-
批准号:2023JJ40913
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:杨慧
-
依托单位:
Calpain调控KCC2通路在脑损伤后海马认知功能障碍中的作用及机制
-
批准号:LY23H090012
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:洪远
-
依托单位:
机械敏感离子通道Piezo1通过Ca2+/Calpain途径对类风湿关节炎成纤维样滑膜细胞迁移侵袭的调控和机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:陈冬莹
-
依托单位: